More good news for Bluebird Bio with CALD gene therapy – pharmaphorum
pharmaphorum |
More good news for Bluebird Bio with CALD gene therapy
pharmaphorum Bluebird Bio has presented encouraging data from its new gene therapy treatment for the rare condition, cerebral adrenoleukodystrophy (CALD). The company is competing with other pioneering firms to develop transformative gene therapies for severe … |
